In Western blot experiments, several nanobodies belonging to different classes specifically recognized a ~40-kDa protein, corresponding to CapG, present in protein extracts obtained from MDA-MB-231 breast cancer cells (see Additional file 1: Figure S1). Here, CAPG is linked to breast carcinoma.